Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent the onset of AD and age-related cognitive decline.
Epistemonikos ID: 37f42c197af7154ceeae37724691806eef6d2fb2
First added on: May 03, 2024